What JRF Ortho does

JRF Ortho, legally Joint Restoration Foundation, Inc., is a Colorado-incorporated non-profit organization founded in 2006 that processes and distributes musculoskeletal allograft tissue for orthopedic and sports medicine surgery. The company supplies three core product categories — osteochondral allografts (OCA), meniscal allografts, and tendon allografts — to orthopedic surgeons and medical facilities exclusively within the United States. JRF's processing capabilities include proprietary low-dose, low-temperature irradiation sterilization (9.5–15 kGy achieving Sterility Assurance Level of 10⁻⁶), a proprietary bioburden reduction step, and aseptic tissue handling without irradiation. Operations are conducted at FDA-registered, AATB-accredited tissue banking facilities in Colorado (Centennial) and California (San Leandro), with documented compliance with 21 CFR Part 1271, ISO 13485, and CLIA.

The product portfolio spans sterile, aseptic, and presutured tendon constructs — including branded lines such as VersaGraft, SpeedGraft, GraftLink XL, and PilotGraft — many of which are assembled to Arthrex specifications for compatibility with Arthrex surgical implant systems (SwiveLock anchors, TightRope devices, FiberLoop suture). JRF has pioneered several innovation products, including fresh distal tibial allografts for glenoid reconstruction (used clinically since 2008 with Dr. Matthew Provencher), fresh talus allografts for Hill-Sachs defects, and matched patella/trochlea OCA grafts for patellofemoral dysplasia. The company self-identifies as the largest provider of cartilage restoration allografts and references an independent study in which 96% of customers report that JRF outperforms any similarly used supplier.

JRF operates a sales-led B2B go-to-market model, distributing products through a direct sales team, an online ordering portal (portal.jrfortho.org), and a network of healthcare distributors across the United States. Pricing is quote-based and transactional, with fees tied to processing, preservation, quality control, and storage of human tissue under the National Organ Transplant Act. The company maintains surgeon advisory groups (MOCA, MERCuRE) and emphasizes clinical evidence through publications and case studies. Geographic operations are restricted to the United States per the Graft Terms and Conditions; there is no disclosed international activity, no funding rounds, and no M&A.

Name

JRF Ortho

Legal name

Joint Restoration Foundation, Inc.

Website

https://jrfortho.org

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

JRF Ortho is a US non-profit tissue bank that processes and supplies osteochondral, meniscus, and tendon allografts to orthopedic surgeons, hospitals, and distributors, claiming the largest share of cartilage restoration allografts in the US market.

Ownership category

akta.pro rank

Product category

Orthopedic Allograft Tissue

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)

akta.pro secondary industry

Orthopedic Surgery (Operative Orthopedics) (HLAKALAC)

Keywords

• Orthopedic allograft tissue
• Musculoskeletal tissue bank
• Sports medicine allografts
• Cartilage restoration grafts
• Ligament reconstruction tendons

Headquarters

HQ city

Centennial

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Allograft tissue products: JRF Ortho supplies allograft products (osteochondral allografts, meniscus, tendons) to medical facilities based on orders placed. The company processes, tests, handles and stores tissue products in accordance with AATB standards and FDA requirements. Fees are charged for transportation, processing, preservation, quality control and storage of human tissue as permitted under the National Organ Transplant Act.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

JRF Ortho (Joint Restoration Foundation, Inc.) is a non-profit tissue bank that processes, tests, stores, and supplies human musculoskeletal allografts (osteochondral allografts, meniscus, and tendons) to orthopedic surgeons and medical facilities in the United States for sports medicine and joint restoration procedures. The company charges transaction-based fees for processing, preservation, quality control, storage, and transportation of tissue products ordered through its online portal.

Product overview

JRF Ortho operates as a non-profit organization specializing in allograft joint restoration for orthopedic surgeons. The company offers a comprehensive portfolio organized around three core product lines: Osteochondral Allografts (OCA) for cartilage restoration, Meniscus Allografts, and Tendon Allografts. The tendon portfolio spans multiple processing methods (presutured sterile, nonsutured sterile, and aseptic) and includes branded constructs like VersaGraft, SpeedGraft, GraftLink XL, and PilotGraft—many designed for compatibility with Arthrex surgical systems. Beyond standard offerings, JRF Ortho pursues innovation through specialized products such as Distal Tibial Allografts for glenoid reconstruction, Talus OCA for Hill-Sachs lesions, and Patella/Trochlea OCA for patellofemoral defects. Customers access products through a dedicated online ordering portal at portal.jrfortho.org.

Differentiator

Problem solved

Functional benefit

Products and services

• Osteochondral Allografts (OCA) Fresh osteochondral allografts that allow surgeons to transplant mature hyaline cartilage with viable chondrocytes and subchondral bone in an intact unit for cartilage restoration procedures.
• Meniscus Allografts Meniscal allograft products with precut bone block options enabling meniscal transplantation to improve biomechanics and restore function for daily activities.
• Presutured Sterile Tendons Sterile preassembled tendon constructs with Arthrex sutures offering off-the-shelf solutions for ligament reconstruction including MPFL, AC Joint, and lateral ankle procedures.
• Nonsutured Aseptic Tendons Tendon allografts processed aseptically without irradiation to preserve biomechanical integrity for ligament reconstruction procedures.
• Nonsutured Sterile Tendons Sterile tendon allografts processed with low-dose irradiation achieving Sterility Assurance Level (SAL) of 10-6 for ligament repair procedures.
• VersaGraft Tendon Sterile presutured tendon construct assembled to Arthrex specifications for MPFL repair, AC Joint repair, and lateral ankle reconstruction (150-250mm length, 4.5mm diameter).
• VersaGraft 3.5 Tendon Compact sterile tendon construct variant designed for procedures requiring 3.5mm diameter specifications.
• SpeedGraft QuadLink Tendon Presutured quadruple-strand tendon construct for enhanced graft strength in ligament reconstruction procedures.
• SpeedGraft Achilles Tendon Presutured Achilles tendon allograft with bone block option for ACL, PCL reconstruction or tendon soft tissue augmentation.
• SpeedGraft Tendon Presutured sterile tendon allograft for ligament reconstruction procedures.
• GraftLink XL Tendon Extended-length presutured tendon allograft for procedures requiring larger graft dimensions.
• PilotGraft BTB Tendon Bone-tendon-bone allograft with presutured preparation for cruciate ligament reconstruction.
• Achilles Tendon (Aseptic) Aseptic Achilles tendon allograft with optional bone block, aseptically processed without irradiation.
• Double Strand Tendon (Aseptic) Aseptic double-strand tendon allografts (Anterior Tibialis, Posterior Tibialis, Semitendinosus, Gracilis, Peroneus Longus) for joint stabilization procedures.
• Patellar Tendon (Aseptic) Aseptic patellar tendon allograft available in preshaped, whole, and hemi configurations for cruciate ligament reconstruction.
• Quadriceps Tendon (Aseptic) Aseptic quadriceps tendon allograft with favorable stiffness profile and preshaped 10mm option for cruciate ligament reconstruction.
• Quadruple Strand Tendon (Aseptic) Aseptic quadruple-strand tendon construct using Semitendinosus and Gracilis for ACL, PCL reconstruction or tendon soft tissue augmentation.
• Single Strand Tendon (Aseptic) Aseptic single-strand tendon allografts (Anterior Tibialis, Semitendinosus, Gracilis) for smaller joint reconstruction including ankle, MPFL, ALL, and AC joint procedures.
• Double Strand Tendon (Sterile) Sterile double-strand tendon allografts with ultra-low dose irradiation (9.5-15 kGy) for knee, ankle, and shoulder stabilization procedures.
• Achilles Tendon (Sterile) Sterile Achilles tendon allograft with and without bone block, processed with ultra-low dose irradiation for ACL, PCL reconstruction.
• Patellar Tendon (Sterile) Sterile patellar tendon allograft available in preshaped (10mm, 11mm), whole, and hemi configurations with bone-to-bone fixation capabilities.
• Single Strand Tendon (Sterile) Sterile single-strand tendon allografts (Anterior Tibialis, Gracilis) with ultra-low dose frozen irradiation for ligament repair procedures.
• Quadriceps Tendon (Sterile) Sterile quadriceps tendon allograft with and without bone block, processed with ultra-low dose irradiation for cruciate ligament reconstruction.
• Quadruple Strand Tendon (Sterile) Sterile quadruple-strand tendon allograft for ACL reconstruction replicating native ligament structure.
• Distal Tibial Allograft Fresh distal tibial allograft pioneered by Dr. Matthew Provencher for glenoid bone defect reconstruction, achieving restoration of the glenoid arc with solid bone and smooth cartilage.
• Talus Osteochondral Allograft Fresh talus allografts for addressing large Hill-Sachs and Reverse Hill-Sachs defects, offering consistent radius of curvature for effective treatment.
• Patella/Trochlea OCA Matched patella and trochlea OCA grafts for patients with dysplasia, plus isolated focal defect reconstruction for the patellofemoral joint.
• Precut Fresh OCA Cores Pre-cut fresh osteochondral allograft cores for the treatment of full-thickness osteochondral lesions.
• JRF Ortho Online Order Portal Web-based portal for orthopedic surgeons and distributors to manage allograft orders, access account information, and streamline the procurement process.

Quantifiable outcome

• 96% of customers feel JRF Ortho outperforms any similarly used supplier (independent study)

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature4 records

Partnerships

One partnership is on record.

• ArthrexcoreTechnology or IntegrationArthrex provides suture specifications (FiberLoop Suture, SwiveLock anchors, TightRope implants) used in JRF Ortho's presutured tendon products including VersaGraft, SpeedGraft, GraftLink, and VersaGraft 3.5. JRF assembles tendons according to Arthrex specifications, ensuring presutured tendons meet requirements for multiple surgical applications including MPFL reconstruction, lateral ankle reconstruction, and AC joint repair.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• RTI Surgical: RTI Surgical is a tissue-based implant manufacturer serving orthopedic and sports medicine surgeons with allograft and synthetic implants — a directly comparable competitor to JRF's allograft joint restoration offering.
• AlloSource: AlloSource is a major non-profit tissue bank that processes and distributes allografts for orthopedic sports medicine and joint restoration, competing head-to-head with JRF's OCA, meniscus, and tendon product lines.
• MTF Biologics: MTF Biologics (Musculoskeletal Transplant Foundation) is the largest US tissue bank and a direct competitor across allograft joint restoration, tendons, meniscus, and osteochondral grafts; it overlaps directly with JRF in orthopedic sports medicine allografts.
• LifeNet Health: LifeNet Health is a leading allograft processor with deep musculoskeletal and sports medicine offerings, including osteochondral, meniscus, and tendon allografts that directly compete with JRF Ortho's portfolio.

Broad incumbents

• Arthrex: Arthrex is the dominant orthopedic sports medicine device company and JRF's core strategic partner (presutured tendons use Arthrex sutures and anchors); it also competes broadly in the orthopedic surgical workflow in which JRF's allografts are consumed.
• Conmed Corporation: Conmed is an established orthopedic and sports medicine medical device company that competes for surgical supplies and biologic implants used in the same procedures as JRF's allografts.
• Stryker: Stryker is a large orthopedic device incumbent with sports medicine and biologics offerings that sit alongside (and partially overlap with) the surgical workflow where JRF's allografts are used.
• Smith & Nephew: Smith & Nephew operates a broad sports medicine and orthopedic portfolio (including regenerative biologics via Osiris) that overlaps with JRF's orthopedic allograft applications and competes for surgeon share of wallet.

Emerging players

• Bioventus: Bioventus sells orthopedic biologics and sports medicine therapies that partially overlap with JRF's allograft joint restoration value proposition, especially in cartilage and soft tissue repair.
• Vericel Corporation: Vericel markets MACI, an autologous chondrocyte implantation product for cartilage repair, directly competing with JRF's osteochondral allografts in the cartilage restoration indication that is JRF's core market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks3 records

Key highlights6 records

Customer concentration

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about JRF Ortho